Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Nancy A. Melville

    News

    WHO: Smoking cessation reduces risk of type 2 diabetes up to 40%

    Author:
    Nancy A. Melville
    Publish date: November 20, 2023

    Key misconceptions among smokers with type 2 diabetes that can prevent cessation include concerns about post-cessation weight gain, the influence...

    • Read More

    News

    Newly approved myasthenia gravis drug shows sustained benefits in early responders

    Author:
    Nancy A. Melville
    Publish date: November 15, 2023

    “This self-administered medication allows patients to be more independent and can even travel since it is not dependent on an infusion center.”

    • Read More

    News

    Chemotherapy-induced peripheral neuropathy tied to compromised executive function

    Author:
    Nancy A. Melville
    Publish date: November 15, 2023

    Chemotherapy-related mobility declines in CIPN survivors are likely due to both neuromuscular and executive dysfunction.

    • Read More

    News

    First new treatment in 30 years for rare disease is effective, tolerable, convenient

    Author:
    Nancy A. Melville
    Publish date: November 8, 2023

    A new subcutaneous injectable showed efficacy and tolerability in patients with chronic inflammatory demyelinating polyneuropathy.

    • Read More

    News

    Duchenne muscular dystrophy gene therapy safe, effective at 4 years

    Author:
    Nancy A. Melville
    Publish date: November 7, 2023

    “What’s really striking, and in my mind the most impressive, is that when you follow these patients out 3 or 4 years ... you see there is this...

    • Read More

    News

    PD-1 inhibitor improves outcomes in NHL subtype

    Author:
    Nancy A. Melville
    Publish date: November 1, 2023

    With toripalimab and radiotherapy, progression-free survival at 2 years is high for extranodal NK/T-cell lymphoma in those who respond poorly to...

    • Read More

    News

    Ocular MALT lymphoma: Radiation reduces relapse

    Author:
    Nancy A. Melville
    Publish date: October 26, 2023

    Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.

    • Read More

    News

    Nonsurgical option for more large thyroid nodule patients?

    Author:
    Nancy A. Melville
    Publish date: October 11, 2023

    The implication is that nonsurgical options such as radiofrequency ablation may be appropriate for more patients than realized.

    • Read More

    News

    Thyroid cancer increase observed in transgender female veterans

    Author:
    Nancy A. Melville
    Publish date: October 6, 2023

    “I would characterize the trends in our data as being potentially suggestive or hypothesis generating – not conclusive.”

    • Read More

    News

    Hold blood thinners during thyroid nodule biopsy?

    Author:
    Nancy A. Melville
    Publish date: October 4, 2023

    “While we can never assume that [the events occurred] because the blood-thinner therapy was held, the timing within 48 hours is certainly very...

    • Read More

    News

    Triple therapy boosts anaplastic thyroid cancer survival

    Author:
    Nancy A. Melville
    Publish date: October 2, 2023

    "The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor...

    • Read More

    News

    What potential does AI offer for endocrinology?

    Author:
    Nancy A. Melville
    Publish date: September 28, 2023

    “A typical indication is fracture detection, not in terms of replacing expert radiologists or orthopedists but rather in terms of supporting those...

    • Read More

    News

    Dispelling clinicians’ misconceptions about sickle cell disease

    Author:
    Nancy A. Melville
    Publish date: September 28, 2023

    Among clinicians and their patients, widespread myths about sickle cell disease can stand in the way of adequate treatment.

    • Read More

    News

    Pediatrician with SCD gives her young patients hope

    Author:
    Nancy A. Melville
    Publish date: September 27, 2023

    A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.

    • Read More

    News

    Adhering to endocrine therapy is hard. What can be done?

    Author:
    Nancy A. Melville
    Publish date: September 26, 2023

    Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties